Comment on

• Prevalence of metabolic syndrome among Australians with severe mental illness.

  John AP, Koloth R, Dragovic M, Lim SC. John AP, et al. Med J Aust. 2009 Feb 16;190(4):176-9. doi: 10.5694/j.1326-5377.2009.tb02342.x. Med J Aust. 2009. PMID: 19220180
• Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm.

  Waterreus AJ, Laugharne JD. Waterreus AJ, et al. Med J Aust. 2009 Feb 16;190(4):185-9. doi: 10.5694/j.1326-5377.2009.tb02344.x. Med J Aust. 2009. PMID: 19220182 Review.
• Clozapine-induced cardiotoxicity: a clinical update.

  Layland JJ, Liew D, Prior DL. Layland JJ, et al. Med J Aust. 2009 Feb 16;190(4):190-2. doi: 10.5694/j.1326-5377.2009.tb02345.x. Med J Aust. 2009. PMID: 19220183
• Ocular pigmentation associated with clozapine.

  Borovik AM, Bosch MM, Watson SL. Borovik AM, et al. Med J Aust. 2009 Feb 16;190(4):210-1. doi: 10.5694/j.1326-5377.2009.tb02353.x. Med J Aust. 2009. PMID: 19220190